RTX vs VRTX · P/E 36, rev $88.60B vs P/E 30, rev $12.00B
RTX Corporation (RTX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the RTX and VRTX stock pages for the full models.
Not investment advice.